184 related articles for article (PubMed ID: 26762562)
1. Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Carcinoma.
Giroux Leprieur E; Vieira T; Antoine M; Rozensztajn N; Rabbe N; Ruppert AM; Lavole A; Cadranel J; Wislez M
Clin Lung Cancer; 2016 Jul; 17(4):301-8. PubMed ID: 26762562
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.
Raz G; Allen KE; Kingsley C; Cherni I; Arora S; Watanabe A; Lorenzo CD; Edwards V DK; Sridhar S; Hostetter G; Weiss GJ
Lung Cancer; 2012 May; 76(2):191-6. PubMed ID: 22115706
[TBL] [Abstract][Full Text] [Related]
3. The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.
Zhang H; Hu L; Cheng M; Wang Q; Hu X; Chen Q
Oncol Rep; 2020 Dec; 44(6):2610-2620. PubMed ID: 33125122
[TBL] [Abstract][Full Text] [Related]
4. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
[TBL] [Abstract][Full Text] [Related]
6. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
[TBL] [Abstract][Full Text] [Related]
7. Gli1 mediates lung cancer cell proliferation and Sonic Hedgehog-dependent mesenchymal cell activation.
Bermudez O; Hennen E; Koch I; Lindner M; Eickelberg O
PLoS One; 2013; 8(5):e63226. PubMed ID: 23667589
[TBL] [Abstract][Full Text] [Related]
8. Genetic landscape and ligand-dependent activation of sonic hedgehog-Gli1 signaling in chordomas: a novel therapeutic target.
Yang C; Yong L; Liang C; Li Y; Ma Y; Wei F; Jiang L; Zhou H; He G; Pan X; Hai B; Wu J; Xu Y; Liu Z; Liu X
Oncogene; 2020 Jun; 39(24):4711-4727. PubMed ID: 32404987
[TBL] [Abstract][Full Text] [Related]
9. Effects of the hedgehog inhibitor GDC-0449, alone or in combination with dasatinib, on BCR-ABL-positive leukemia cells.
Okabe S; Tauchi T; Tanaka Y; Katagiri S; Ohyashiki K
Stem Cells Dev; 2012 Nov; 21(16):2939-48. PubMed ID: 22642671
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy.
Ma K; Xu W; Wang C; Li B; Su K; Li W
Cancer Biomark; 2017; 18(3):297-303. PubMed ID: 27983538
[TBL] [Abstract][Full Text] [Related]
11. Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production.
Fan J; Zhang X; Wang S; Chen W; Li Y; Zeng X; Wang Y; Luan J; Li L; Wang Z; Sun X; Shen B; Ju D
Cell Death Dis; 2019 Aug; 10(9):626. PubMed ID: 31427566
[TBL] [Abstract][Full Text] [Related]
12. The effects of sonic hedgehog signaling pathway components on non-small-cell lung cancer progression and clinical outcome.
Hwang J; Kang MH; Yoo YA; Quan YH; Kim HK; Oh SC; Choi YH
World J Surg Oncol; 2014 Aug; 12():268. PubMed ID: 25141859
[TBL] [Abstract][Full Text] [Related]
13. STAT3 activation and aberrant ligand-dependent sonic hedgehog signaling in human pulmonary adenocarcinoma.
Yang Q; Shen SS; Zhou S; Ni J; Chen D; Wang G; Li Y
Exp Mol Pathol; 2012 Oct; 93(2):227-36. PubMed ID: 22554932
[TBL] [Abstract][Full Text] [Related]
14. Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
Lee SH; Choi SI; Lee JS; Kim CH; Jung WJ; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Cancer Res Treat; 2017 Jan; 49(1):141-149. PubMed ID: 27188201
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significances of hedgehog signaling pathway in non-Hodgkin's lymphoma].
Zhang XY; Liu XQ; Ge XL; Fen LL; Wang X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1129-33. PubMed ID: 22040957
[TBL] [Abstract][Full Text] [Related]
16. Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.
Catenacci DV; Junttila MR; Karrison T; Bahary N; Horiba MN; Nattam SR; Marsh R; Wallace J; Kozloff M; Rajdev L; Cohen D; Wade J; Sleckman B; Lenz HJ; Stiff P; Kumar P; Xu P; Henderson L; Takebe N; Salgia R; Wang X; Stadler WM; de Sauvage FJ; Kindler HL
J Clin Oncol; 2015 Dec; 33(36):4284-92. PubMed ID: 26527777
[TBL] [Abstract][Full Text] [Related]
17. Gli promotes tumor progression through regulating epithelial-mesenchymal transition in non-small-cell lung cancer.
Jiang L; Huang J; Hu Y; Lu P; Luo Q; Wang L
J Cardiothorac Surg; 2020 Jan; 15(1):18. PubMed ID: 31931858
[TBL] [Abstract][Full Text] [Related]
18. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.
Bora-Singhal N; Perumal D; Nguyen J; Chellappan S
Neoplasia; 2015 Jul; 17(7):538-51. PubMed ID: 26297432
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase inhibitor SU6668 attenuates positive regulation of Gli proteins in cancer and multipotent progenitor cells.
Piirsoo A; Kasak L; Kauts ML; Loog M; Tints K; Uusen P; Neuman T; Piirsoo M
Biochim Biophys Acta; 2014 Apr; 1843(4):703-14. PubMed ID: 24418624
[TBL] [Abstract][Full Text] [Related]
20. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo.
Dennler S; André J; Alexaki I; Li A; Magnaldo T; ten Dijke P; Wang XJ; Verrecchia F; Mauviel A
Cancer Res; 2007 Jul; 67(14):6981-6. PubMed ID: 17638910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
